SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-16-001813
Filing Date
2016-02-25
Accepted
2016-02-25 17:00:25
Documents
1
Period of Report
2016-02-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 9490
  Complete submission text file 0001562180-16-001813.txt   11072
Mailing Address C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address
Behrens Mary Taylor (Reporting) CIK: 0001309855 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 161456703

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations